Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXRAZOXANE Cause Neoplasm progression? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Neoplasm progression have been filed in association with DEXRAZOXANE (Dexrazoxane). This represents 1.2% of all adverse event reports for DEXRAZOXANE.

13
Reports of Neoplasm progression with DEXRAZOXANE
1.2%
of all DEXRAZOXANE reports
6
Deaths
8
Hospitalizations

How Dangerous Is Neoplasm progression From DEXRAZOXANE?

Of the 13 reports, 6 (46.2%) resulted in death, 8 (61.5%) required hospitalization.

Is Neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXRAZOXANE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does DEXRAZOXANE Cause?

Febrile neutropenia (315) Off label use (266) Clostridium difficile colitis (91) Cellulitis (84) Product use in unapproved indication (84) Pyrexia (81) Fungal infection (74) Bacterial infection (73) Lymphoid tissue hypoplasia (72) Lymphopenia (70)

What Other Drugs Cause Neoplasm progression?

PALBOCICLIB (10,885) SUNITINIB MALATE (1,920) CYCLOPHOSPHAMIDE (1,588) CARBOPLATIN (1,370) AXITINIB (1,315) DOXORUBICIN (1,276) LETROZOLE (1,225) PACLITAXEL (1,180) CRIZOTINIB (1,161) VINCRISTINE (1,106)

Which DEXRAZOXANE Alternatives Have Lower Neoplasm progression Risk?

DEXRAZOXANE vs DEXTRAN 70\HYPROMELLOSE 2910 DEXRAZOXANE vs DEXTROAMPHETAMINE DEXRAZOXANE vs DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE DEXRAZOXANE vs DEXTROMETHORPHAN DEXRAZOXANE vs DEXTROMETHORPHAN HYDROBROMIDE

Related Pages

DEXRAZOXANE Full Profile All Neoplasm progression Reports All Drugs Causing Neoplasm progression DEXRAZOXANE Demographics